AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Vildavo-M 500 Tablet

Prescription Icon
Prescription Required

Marketer

Avolife Pharmaceutical Private Limited

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildavo-M 500 Tablet

Combiflor 500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps avert severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Combiflor 500mg may be used as monotherapy or in conjunction with other antidiabetic treatments. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose readings, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar control significantly reduces future health risks. Continued commitment to the prescribed diet and exercise plan is crucial. Lifestyle significantly impacts diabetes management. Commonly reported adverse effects include nausea, vomiting, diarrhea, indigestion, headache, pharyngitis, asthenia, GERD, diaphoresis, and anorexia. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates understanding its recognition and management. This medication isn't universally suitable. Prior to commencing treatment, inform your doctor of any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals require physician consultation before use. Potential drug interactions necessitate disclosure of all medications to your physician to ensure treatment safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout the treatment course.

Uses of Vildavo-M 500 Tablet

Managing type 2 diabetes

Major Benefits of Vildavo-M 500 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Vildavo-M 500 Tablet with a meal.

Common Side effects of Vildavo-M 500 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildavo-M 500 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Vildavo-M 500 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Vildavo-M 500 Tablet works:

Vildavo-M 500mg tablets contain a dual-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildavo-M 500 Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vildavo-M 500 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Vildavo-M 500 Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with impaired kidney function, Vildavo-M 500 Tablet requires careful administration. Dosage modification may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver conditions should likely abstain from Vildavo-M 500 Tablet due to potential safety concerns. A physician's consultation is recommended.

What if you forget to take Vildavo-M 500 Tablet :

Should you forget a Vildavo-M 500 Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual medication schedule. Never take a double dose.

Facts to Know About Vildavo-M 500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildavo-M 500 Tablet

Vildavo-M 500 Tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication can lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may occur, especially if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildavo-M 500 Tablet. If vomiting occurs, sip small amounts of fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without first talking to your doctor.
Vildavo-M 500 Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildavo-M 500 Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildavo-M 500 Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Vildavo-M 500 Tablets and seek immediate medical attention.
Prolonged Vildavo-M 500 Tablet use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Vildavo-M 500 Tablet is safe when used as directed by your doctor. However, even with correct dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if taking insulin or sulphonylurea). Report any persistent issues to your physician.
Vildavo-M 500 Tablet
103
MRP 119
13% off